Lipoprotein(a) as a cardiovascular risk factor: current status

Nordestgaard, Borge; Chapman, M.; Ray, Kausik; Boren, Jan; Andreotti, Felicita; Watts, Gerald; Ginsberg, Henry; Amarenco, Pierre; Catapano, Alberico; Descamps, Olivier; Fisher, Edward; Kovanen, Petri; Kuivenhoven, Jan; Lesnik, Philippe; Masana, Luis; Reiner, Zeljko; Taskinen, Marja-Riitta; Tokgozoglu, Lale; Tybjaerg-Hansen, Anne

doi:10.1093/eurheartj/ehq386

Lipoprotein(a) as a cardiovascular risk factor: current status

Nordestgaard B. G. , Chapman M. J. , Ray K., Boren J., Andreotti F., Watts G. F. , ...More

EUROPEAN HEART JOURNAL, vol.31, no.23, pp.2844-2855, 2010 (Journal Indexed in SCI)

Publication Type: Article / Article
Volume: 31 Issue: 23
Publication Date: 2010
Doi Number: 10.1093/eurheartj/ehq386
Title of Journal : EUROPEAN HEART JOURNAL
Page Numbers: pp.2844-2855
Keywords: Lipids, Hyperlipidemia, Prevention, Myocardial infarction, Stroke, CORONARY-HEART-DISEASE, OXIDIZED PHOSPHOLIPIDS, LP(A) LIPOPROTEIN, NATIONAL-HEART, APOLIPOPROTEIN(A), ASSOCIATION, ATHEROSCLEROSIS, INSIGHTS, LDL, MEN

Abstract

The aims of the study were, first, to critically evaluate lipoprotein(a) [Lp(a)] as a cardiovascular risk factor and, second, to advise on screening for elevated plasma Lp(a), on desirable levels, and on therapeutic strategies.